Persistence of MERS-CoV-Spike-Specific B Cells and Antibodies after Late Third Immunization with the MVA-MERS-S Vaccine

The authors performed a longitudinal analysis of immune responses following immunization with the modified vaccinia virus Ankara (MVA)-based vaccine MVA-Middle East respiratory syndrome (MERS)-S encoding the MERS-CoV-spike protein.